Trial Profile
An Observational Study to Assess Patient Satisfaction and Control of Psoriasis With Calcipotriene/Betamethasone Dipropionate (Taclonex) Topical Suspension, and Effect on Quality of Life
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Feb 2018
Price :
$35
*
At a glance
- Drugs Betamethasone-dipropionate/calcipotriol (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Acronyms APPEAL
- Sponsors LEO Pharma
- 21 Jul 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 19 Nov 2013 New trial record